The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis
Cerebrovascular Diseases Extra · 02.01.2025 · 15 (1) · 68-72
DOI: 10.1159/000543331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 02.01.2025. Verfasst von Songchai Kittipanprayoon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Hatyai Hospital, Songkhla, Thailand. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2C19, Intracranial Arteriosclerosis, Polymorphism, Genetic, Pharmacogenomic Variants. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Clopidogrel and aspirin were proved to have benefit in symptomatic intracranial stenosis. CYP2C19 polymorphism (CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles) affects efficacy of clopidogrel. Epidemiologic study of CYP2C19 polymorphism has been conducted in Thai population. There was no data showed the frequency of allelic variants of CYP2C19 in Thai symptomatic intracranial stenosis patients. The aim of this study was to determine the prevalence of CYP2C19 polymorphism in symptomatic intracranial stenosis patients.
Methods
The study group included 100 Thai symptomatic intracranial stenosis patients. Genotyping of CYP2C19 alleles (CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles) was carried out by real-time polymerase chain reaction (rt-PCR) technique.
Results
The allele frequency of CYP2C19*1, CYP2C19*2, CYP2C19*3, and CYP2C19*17 were 70.5%, 26%, 2.5%, and 1%, respectively. The result showed that 53% of symptomatic intracranial stenosis patients are normal metabolizers, while intermediate and poor metabolizer were 36 and 10 percent, respectively.
Conclusion
Almost one-half of Thai symptomatic intracranial stenosis patients were intermediate or poor metabolizers. Usage of combination of aspirin and clopidogrel might not be effective in this group of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Hatyai Hospital, Songkhla, Thailand.
- Chulalongkorn Stroke Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, pongpatv@yahoo.com.
- Chulalongkorn Stroke Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Zitieren
APA
Kittipanprayoon, S., Vorasayan, P., Chutinet, A., Chariyavilaskul, P., & Suwanwela, N. C. (2025). The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis. Cerebrovascular Diseases Extra, 15(1), 68-72. https://doi.org/10.1159/000543331
Vancouver
Kittipanprayoon S, Vorasayan P, Chutinet A, Chariyavilaskul P, Suwanwela NC. The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis. Cerebrovascular Diseases Extra. 2025;15(1):68-72. doi:10.1159/000543331
BibTeX
@article{Kittipanprayoon2025,
author = {Kittipanprayoon, Songchai and Vorasayan, Pongpat and Chutinet, Aurauma and Chariyavilaskul, Pajaree and Suwanwela, Nijasri C},
title = {The Prevalence of CYP2C19 Polymorphism in Patients with Symptomatic Intracranial Atherosclerosis},
journal = {Cerebrovascular Diseases Extra},
year = {2025},
volume = {15},
number = {1},
pages = {68--72},
doi = {10.1159/000543331}
}
EUVIMED